Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease

被引:132
|
作者
Ananthapanyasut, Wanwarat
Napan, Sirikarn [2 ]
Rudolph, Earl H.
Harindhanavudhi, Tasma
Ayash, Husam
Guglielmi, Kelly E.
Lerma, Edgar V. [1 ]
机构
[1] Univ Illinois, Dept Med, Nephrol Sect, Advocate Christ Med Ctr, Oak Lawn, IL 60453 USA
[2] Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 5卷 / 02期
关键词
C-REACTIVE PROTEIN; HEART-FAILURE; RISK-FACTORS; MORTALITY; INFLAMMATION; ARRHYTHMIAS; PROGRESSION; POPULATION; PREVENTION; METOPROLOL;
D O I
10.2215/CJN.03170509
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Chronic kidney disease (CKD) increases systemic inflammation, which is implicated in development and maintenance of atrial fibrillation (AF); therefore, we hypothesized that the prevalence of AF would be increased among nondialysis patients with CKD. This study also reports independent predictors of the presence of AF in this population. Design, setting, participants, & measurements: A retrospective, cross-sectional analysis of 1010 consecutive nondialysis patients with CKD from two community-based hospitals was conducted. Estimated GFRs (eGFRs) were calculated using the Modification of Diet in Renal Disease (MDRD) equation. Multivariate logistic regression was used to determine independent predictors. Results: Of 1010 nondialysis patients with CKD, 214 (21.2%) had AF. Patients with AF were older than patients without AF (76 +/- 11 versits 63 +/- 15 yr). The prevalence of AF among white patients (42.7%) was higher than among black patients (12.7%) or other races (5.7%). In multivariate analyses, age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure were identified as independent predictors of the presence of AF. Although serum high-sensitivity C-reactive protein levels were elevated in our population (5.2 +/- 7.4 mg/L), levels did not correlate with the presence of AF or with eGFR. Finally, eGFR did not correlate with the presence of AF in our population. Conclusions: The prevalence of AF was increased in our population, and independent predictors were age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure. Clin J Am Soc Nephrol 5: 173-181, 2010. doi: 10.2215/CJN.03170509
引用
收藏
页码:173 / 181
页数:9
相关论文
共 50 条
  • [31] The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease
    Simic, Jelena
    Mihajlovic, Miroslav
    Zec, Nevena
    Kovacevic, Vladan
    Marinkovic, Milan
    Mujovic, Nebojsa
    Potpara, Tatjana
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (12) : 937 - 945
  • [32] Prognostic Role of Ambulatory Blood Pressure Measurement in Patients With Nondialysis Chronic Kidney Disease
    Minutolo, Roberto
    Agarwal, Rajiv
    Borrelli, Silvio
    Chiodini, Paolo
    Bellizzi, Vincenzo
    Nappi, Felice
    Cianciaruso, Bruno
    Zamboli, Pasquale
    Conte, Giuseppe
    Gabbai, Francis B.
    De Nicola, Luca
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (12) : 1090 - 1098
  • [33] Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients
    Nelson, Sarah E.
    Shroff, Gautam R.
    Li, Shuling
    Herzog, Charles A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (04):
  • [34] Warfarin Treatment in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease Sins of Omission or Commission?
    Winkelmayer, Wolfgang C.
    Turakhia, Mintu P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (09): : 913 - 915
  • [35] Atrial Fibrillation and Chronic Kidney Disease in Hypertension: A Common and Dangerous Triad
    Tsiachris, Dimitris
    Tsioufis, Costas
    Mazzone, Patrizio
    Katsiki, Niki
    Stefanadis, Christodoulos
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (01) : 111 - 120
  • [36] Prevalence and predictors of atrial fibrillation type among individuals with recent onset of atrial fibrillation
    Ruperti, Repilado Francisco J.
    Doerig, Laura
    Blum, Steffen
    Aeschbacher, Stefanie
    Krisai, Philipp
    Ammann, Peter
    Erne, Paul
    Moschovitis, Giorgio
    di Valentino, Marcello
    Shah, Dipen
    Schlapfer, Jurg
    Stempfel, Samuel
    Kuhne, Michael
    Sticherling, Christian
    Osswald, Stefan
    Conen, David
    SWISS MEDICAL WEEKLY, 2018, 148
  • [37] Atrial fibrillation and chronic kidney disease: A bad combination
    Kiuchi, Marcio Galindo
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2018, 37 (02) : 103 - 105
  • [38] Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management
    Sidhu, Bharat
    Mavilakandy, Akash
    Hull, Katherine L.
    Koev, Ivelin
    Vali, Zakariyya
    Burton, James O.
    Ng, G. Andre
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (04)
  • [39] Insights into Concomitant Atrial Fibrillation and Chronic Kidney Disease
    Wang, Yanan
    Yang, Yi
    He, Fan
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (03)
  • [40] Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines
    Mlodawska, Elzbieta
    Tomaszuk-Kazberuk, Anna
    Lopatowska, Paulina
    Musial, Wlodzimierz J.
    Malyszko, Jolanta
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (05): : 353 - 362